Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
TRVI.OQ - Trevi Therapeutics Inc
Q3 2022 Trevi Therapeutics Inc Earnings Call
Nov 10, 2022 / 09:30PM GMT
=====================
Conference Call Participants
=====================
* >>Jennifer Good - CEO
* >>Lisa Delfini - CFO
* >>Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
* >>Serge Belanger - Needham & Company, LLC, Research Division
=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------
Good afternoon, and welcome to the Trevi Therapeutics Q3 2022 Earnings Conference Call. (Operator Instructions) Please note, today's event is being recorded.
Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private